2008 annual financial data

Rigel Pharmaceuticals 2008 Operating margin

Direct answer

Operating margin was Not calculable.

Operating income was -136,714,000 USD and net income was -132,346,000 USD.
Operating cash flow was -103,518,000 USD.

Get free Rigel Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-136,714,000 USD
Net income
-132,346,000 USD
Operating cash flow
-103,518,000 USD